Shaye Mandle, who has led Minnesota’s Medical Alley Association since 2014, is leaving the medtech trade group for the Biotechnology Innovation Organization (BIO) in Washington, D.C.
Mandle will join BIO as COO on March 1 after nearly 10 years at Medical Alley, first as COO and VP of government relations and then as president & CEO.
Steffen Hovard, former chair of the Medical Alley board of directors, is returning to serve as the organization’s interim president & CEO. Medical Alley will conduct a national search to select Mandle’s successor, according to a news release.
Get the full story on our sister site, Medical Design & Outsourcing.